Skip to main content

TRODELVY

NDC 55135-132 · Gilead Sciences, Inc.

Generic nameSACITUZUMAB GOVITECAN

Dosage formPOWDER, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)SACITUZUMAB GOVITECAN

Strength180 mg/1

Marketing categoryBLA

Packages

55135-132-01 — 1 VIAL in 1 BOX (55135-132-01) / 1 POWDER, FOR SOLUTION in 1 VIAL

Billed under HCPCS

J9317 — Injection, sacituzumab govitecan-hziy, 2.5 mg Medicare Part B payment limit (ASP + 6%): $37.64

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels